BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17432104)

  • 1. Sm antibodies increase risk of death in systemic lupus erythematosus.
    Hitchon CA; Peschken CA
    Lupus; 2007; 16(3):186-94. PubMed ID: 17432104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic value of anti-RNP/Sm and anti-Ro/La antibodies in lupus nephropathy].
    López-Longo FJ; López-Gómez JM; Jofre Ibáñez R; Escalona M; Rodríguez-Mahou M
    Rev Clin Esp; 1992 Nov; 191(7):354-9. PubMed ID: 1475460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and prognostic value of autoantibodies in puerto Ricans with systemic lupus erythematosus.
    Vilá LM; Molina MJ; Mayor AM; Peredo RA; Santaella ML; Vilá S
    Lupus; 2006; 15(12):892-8. PubMed ID: 17211998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC; Barcellos KS; Andrade LE
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
    To CH; Petri M
    Arthritis Rheum; 2005 Dec; 52(12):4003-10. PubMed ID: 16320348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity.
    Emad Y; Gheita T; Darweesh H; Klooster P; Gamal R; Fathi H; El-Shaarawy N; Gamil M; Hawass M; El-Refai RM; Al-Hanafi H; Abd-Ellatif S; Ismail A; Rasker J
    Reumatismo; 2018 Jul; 70(2):85-91. PubMed ID: 29976042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical expression of systemic lupus erythematosus with anti-U1-RNP and anti-Sm antibodies].
    López-Longo FJ; González Fernández CM; Rodríguez Mahou M; Grau Simó R; Monteagudo Sáez I; Meno García AC; Carreño Pérez L
    Rev Clin Esp; 1997 May; 197(5):329-35. PubMed ID: 9280966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival impact of autoantibodies in systemic lupus erythematosus.
    Gulko PS; Reveille JD; Koopman WJ; Burgard SL; Bartolucci AA; Alarcón GS
    J Rheumatol; 1994 Feb; 21(2):224-8. PubMed ID: 8182629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens.
    Gaubitz M; Wegmann C; Schotte H; Willeke P; Domschke W
    Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):317-21. PubMed ID: 12030437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinuclear antibodies in systemic lupus erythematosus.
    Fong KY; Boey ML; Howe HS; Feng PH
    Med J Malaysia; 1989 Jun; 44(2):151-5. PubMed ID: 2626124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting molecular patterns of MHC class II alleles associated with the anti-Sm and anti-RNP precipitin autoantibodies in systemic lupus erythematosus.
    Olsen ML; Arnett FC; Reveille JD
    Arthritis Rheum; 1993 Jan; 36(1):94-104. PubMed ID: 7678744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to the Sm antigen: immunological approach to clinical aspects of systemic lupus erythematosus.
    Homma M; Mimori T; Takeda Y; Akama H; Yoshida T; Ogasawara T; Akizuki M
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():188-93. PubMed ID: 2441045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-RO anti-LA anti-RNP antibodies and eletrocardiogram's PR interval in adult patients with systemic lupus erythematosus.
    Costa M; Gameiro Silva MB; Silva JA; Skare TL
    Acta Reumatol Port; 2008; 33(2):173-6. PubMed ID: 18604183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Sm and anti-RNP antibodies.
    Migliorini P; Baldini C; Rocchi V; Bombardieri S
    Autoimmunity; 2005 Feb; 38(1):47-54. PubMed ID: 15804705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of serum anti-DNA topoisomerase I and anti-Sm antibodies: report of 3 cases.
    Kameda H; Kuwana M; Hama N; Kaburaki J; Homma M
    J Rheumatol; 1997 Feb; 24(2):400-3. PubMed ID: 9035005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis.
    Alba P; Bento L; Cuadrado MJ; Karim Y; Tungekar MF; Abbs I; Khamashta MA; D'Cruz D; Hughes GR
    Ann Rheum Dis; 2003 Jun; 62(6):556-60. PubMed ID: 12759294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of antibodies to SM and RNP].
    Dror Y; Slor H; Shoenfeld Y
    Harefuah; 1988 Feb; 114(3):140-3. PubMed ID: 3280443
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-Sm and anti-RNP antibody tests.
    Benito-Garcia E; Schur PH; Lahita R;
    Arthritis Rheum; 2004 Dec; 51(6):1030-44. PubMed ID: 15593352
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoantibodies that stabilize U1snRNP are a significant component of human autoantibodies to snRNP and delay proteolysis of sm antigens in vitro.
    Satoh M; Akaogi J; Kuroda Y; Nacionales DC; Yoshida H; Yamasaki Y; Reeves WH
    J Rheumatol; 2004 Dec; 31(12):2382-9. PubMed ID: 15570638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.